Analyst Ratings for Xeris Pharmaceuticals (XERS)

XERS Rating Summary

XERS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on XERS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.00 (+281%) * Over Last 12-Mos
Rating Score: 8.6 / 10   Percentile Rank: 86%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/17/2021 SVB Leerink Roanna Ruiz New Coverage Outperform
(N/A)
6.00
(N/A)
2.39
(2.10)
-12.13% Details
10/29/2021 H.C. Wainwright Oren Livnat New Coverage Buy
(N/A)
4.00
(N/A)
1.80
(2.10)
16.67% Details
Like XERS Ratings? Also take a look at SBBP, NEOS, ITRM, UTHR

XERS Ratings News